Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$413,500.00
Dec 6, 2021
For-profit organization
Development and validation of a subcutaneous delivery formulation of a bone-healing therapeutic
985072
This project will help the firm develop, optimize and characterize a formulation of their lead therapeutic compound that is suitable for administration via subcutaneous injection. Efficacy of the new formulation will also be functionally validated.
$180,000.00
Jul 10, 2020
For-profit organization
Method Development to Support GLP Toxicology Studies of a Bone-Targeting Drug
954656
This project will help the firm qualify a non-rodent species for future IND-enabling safety studies by supporting the development of species-specific analytical methods as well as methods required for batch analysis and formulation development. It will also support preliminary pharmacological studies in the non-rodent species.
$120,000.00
Dec 17, 2019
For-profit organization
Bioanalytical method development and non-GLP safety studies for a bone-targeting drug
942888
This project will support the firm to develop analytical methods and obtain initial toxicology information for their lead compound that will be used to support future IND-enabling studies.
$50,000.00
Aug 1, 2018
For-profit organization
Evaluation of a bone-promoting agent in local and systemic administration models.
911801
To support upcoming IND filings the firm’s lead candidate bone growth promoting drug will be tested for efficacy in animal (rodent) models, one requiring systemic administration and the other requiring local administration.